Markets Snap a Losing Streak as Pharma Tariffs and a Tropical Threat Loom for Monday

Friday brought a firmer S&P 500 close, rising card APRs after the Fed hike, a bank-impersonation warning from regulators, a Section 232 drug-duty deadline, and Southeast travel watches as Potential Tropical Cyclone Nine organizes.

Morning Briefing

AI Overview

6 stories2 min read

Espresso optional. Clarity mandatory.

U.S. readers head into the weekend with stocks higher on cheaper oil, credit-card bills repricing after the Fed move, a Monday customs cliff for patented drug imports, and a new Atlantic system that could disrupt Bahamas and Southeast travel plans.

S&P 500 finished at 7,743.41 as oil slid and Iran-talk hopes helped end a three-week losing streak.
Prime-linked credit cards are resetting purchase APRs on September billing cycles after the mid-month Fed hike.
FCC and FTC repeat: banks never ask customers to wire money to a "safe account"—hang up and call the number on your card.
Most patented drug imports face 100% Section 232 duty on entries cleared after 12:01 a.m. ET Monday; generics stay exempt.
Branded prescriptions sit on that tariff cliff while patient groups watch which medicines lack generic substitutes.
Potential Tropical Cyclone Nine and Hurricane Humberto raise Fujiwhara uncertainty for Bahamas cruises and Southeast flights.

Photoreal wide shot of Wall Street and the New York Stock Exchange facade at golden hour, traders and pedestrians in motion, American flags, no logos or readable text.

Stocks

S&P 500 Closes at 7,743 as Oil Slide and Iran Talks Hopes End Three-Week Losing Streak

A 3.4% drop in Brent and hopes for U.S.-Iran talks in New York helped the S&P 500 close at 7,743.41, up 0.51%, snapping a three-week losing streak. The Dow led, the Nasdaq lagged, and the 10-year eased from its 5.20% weekly peak.

Nina Okonkwo Sep 26, 2026